Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Balance Sheets

v3.26.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2025
Dec. 31, 2024
Current Assets    
Cash and cash equivalents $ 358,975 $ 13,199
Marketable securities - related party 38,531 82,376
Total Current Assets 397,506 95,575
Total Assets 397,506 95,575
Current Liabilities    
Accounts payable and accrued expenses 359,380 1,718,922
Derivative liability 1,944,806
Notes payable - related party 500,000 106,850
Total Current Liabilities 3,773,845 5,166,681
Total Liabilities 3,773,845 5,166,681
Commitments and Contingencies (Note 7)
Stockholders’ Deficit    
Preferred stock ($0.0001 par; 50,000,000 auth; none issued)
Common stock, $0.0001 par value: authorized 500,000,000, 46,852,319 and 21,674,000 shares issued and outstanding as of December 31, 2025 and 2024, respectively 4,685 2,167
Additional paid-in capital 34,270,622 810,048
Accumulated deficit (37,651,646) (5,883,321)
Total Stockholders’ Deficit (3,376,339) (5,071,106)
Total Liabilities and Stockholders’ Deficit 397,506 95,575
Related Party [Member]    
Current Liabilities    
Accounts payable - related party 926,659 911,659
Short-term advances - related party 18,000 1,731,058
Convertible note payable - net of debt discount 173,192
Nonrelated Party [Member]    
Current Liabilities    
Convertible note payable - net of debt discount $ 25,000 $ 525,000